Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates
- 1 May 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. 28 (5), 412-415
- https://doi.org/10.1097/inf.0b013e3181910e2d
Abstract
Background: Determining the safety and pharmacokinetics of antifungal agents in neonates is important. A previous single-dose pharmacokinetic study of micafungin in neonates demonstrated that doses of 0.75 to 3 mg/kg produced lower plasma micafungin concentrations than in older patients because of increased apparent plasma clearance of micafungin in neonates. The primary objective of this study was to assess the safety and pharmacokinetics of an increased (15 mg/kg/d) dose of micafungin. Methods: A repeated dose, open-label pharmacokinetic, and safety trial of intravenous micafungin in 12 preterm neonates >48 hours of life with suspected systemic infections. Neonates received 15 mg/kg/d of micafungin for 5 days. Blood samples were drawn relative to either the fourth or fifth dose. Systemic exposure was assessed by examination of the plasma area under the curve. Results: The median birth weight and gestational age of the neonates were 775 g and 27 weeks, respectively. No adverse events related to micafungin were detected. The mean area under the curve and clearance for the cohort was 437.5 μg′h/mL and 0.575 mL/min/kg, respectively. The calculated clearance and volume of distribution for neonates was greater than that observed in older children and adults. Conclusions: These data suggest that 15 mg/kg dosing in premature neonates corresponds to an exposure of approximately 5 mg/kg in adults. No adverse events related to micafungin were observed.Keywords
This publication has 20 references indexed in Scilit:
- The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental HematogenousCandidaMeningoencephalitis: Implications for Echinocandin Therapy in NeonatesThe Journal of Infectious Diseases, 2008
- Mucocutaneous candidiasisSeminars in Perinatology, 2003
- Echinocandin antifungal drugsThe Lancet, 2003
- Neonatal Candidemia and End-Organ Damage: A Critical Appraisal of the Literature Using Meta-analytic TechniquesPediatrics, 2003
- Treatment of candidaemia in premature infants: comparison of three amphotericin B preparationsJournal of Antimicrobial Chemotherapy, 2003
- Neonatal Invasive Candidiasis: A Prospective Multicenter Study of 118 CasesAmerican Journal of Perinatology, 2003
- Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic RabbitsAntimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of lifeClinical Pharmacology & Therapeutics, 1993
- Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonatesThe Journal of Pediatrics, 1990
- Pharmacokinetics of Amphotericin B in Infants and ChildrenThe Journal of Infectious Diseases, 1987